Reveals how AI-driven transparency enhances tariff compliance in global supply chains, indicating significant operational improvements.
Volatility is now the baseline condition for global supply chains. Since 2020, overlapping shocks, including pandemic shutdowns, chokepoint disruptions, and stepped-up trade and forced-labour enforcement, have shifted the board agenda from cost and resilience to verifiable transparency. This paper argues that transparency, amplified by artificial intelligence (AI), is the decisive capability for navigating today’s tariff regime and broader regulatory risk. It first demystifies the mechanics of customs, harmonised classification (HS/HTS), and country of origin (COO) determination, explaining why line-item, evidence-grade data is now required. The paper then introduces aligned organisation, data architecture, agile supplier ecosystems, people strategy, and transparent performance systems (ADAPT), a practical, closed-loop leadership framework, and a four-level data/AI operating model that turns master data, supplier disclosures, digital twins, and prescriptive analytics into audit-ready, financially grounded decisions. Case examples illustrate how companies reduce detentions, avoid penalties, protect launches, and reconfigure networks at the ‘speed of risk’. The paper concludes with a 90-day playbook, board-level frequently asked questions (FAQs), and return on investment (ROI) guidance that reframes transparency from a compliance tax to a competitive moat. For senior executives, the mandate is clear: invest in provable data and explainable AI, embed compliance into product and supplier workflows, and manage transparency with the same rigour as working capital. In regulated markets, provability is now the licence to operate, and a durable source of advantage. This article is also included in The Business & Management Collection which can be accessed at https://hstalks.com/business/.
No takes yet. Share an insight, caveat, or question.
Shikha Mehta (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: